Artificial intelligence (AI) in the global drug discovery market is expected to grow at a rate of 30% through 2026
Global Artificial Intelligence (AI) in Drug Discovery Market Report 2022 by The Business Research Company –Global Market Size, Trends and Forecast 2022-2026
LONDON, GREATER LONDON, UK, January 20, 2022 /EINPresswire.com/ — According to ‘Global Artificial Intelligence (AI) in Drug Discovery Market Report 2022 – Global Market Size, Trends and Forecasts 2022-2026′ published by The Business Research Company, the Artificial Intelligence in Drug Discovery market size is expected to grow from $791.83 million in 2021 to $1042.30 million in 2022 at a compound annual growth rate (CAGR) of 31.6%. The market growth is mainly driven by businesses resuming operations and adapting to the new normal while recovering from the impact of COVID-19, which previously led to restrictive lockdown measures involving social distancing , remote working and closing business activities. which resulted in operational difficulties. The AI in drug discovery market is expected to reach $2994.52 million in 2026 with a CAGR of 30.2%. Rising demand for reduction in overall time required for drug discovery process is a key driver propelling artificial intelligence in drug discovery market growth.
Want to know more about artificial intelligence (AI) in the growth of the drug discovery market? Request a sample now:
The artificial intelligence in drug discovery market includes sales of AI for drug discovery and related services. AI for drug discovery is a technology that uses simulation of the process of human intelligence by machines to solve complex problems in the drug discovery process. It helps find new molecules to identify drug targets and develop personalized drugs in the pharmaceutical industry.
Global Artificial Intelligence (AI) in Drug Discovery Market Trends
Major companies operating in the AI drug delivery market are adopting strategic collaborations to research and discover drugs using AI and are gaining popularity in the artificial intelligence in drug discovery market.
Global Artificial Intelligence (AI) in Drug Discovery Market Segments
The global artificial intelligence in drug discovery market is segmented:
By Technology: Deep Learning, Machine Learning
By drug type: small molecule, large molecule
By type of disease: metabolic disease, cardiovascular disease, oncology, neurodegenerative diseases, other
By end users: pharmaceutical companies, biopharmaceutical companies, academic and research institutes, others
By Geography: The global AI in drug discovery market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East & Africa.
To learn more about the global Artificial Intelligence (AI) in Drug Discovery report, visit:
Artificial Intelligence (AI) in Drug Discovery Global Market Report 2022 is part of a series of new reports by The Business Research Company that provides Artificial Intelligence (AI) in Drug Discovery Market analysis drug discovery, artificial intelligence (AI) in drug discovery market analysis, forecast global artificial intelligence (AI) in drug discovery market size and growth, share artificial intelligence (AI) in drug discovery market, artificial intelligence (AI) in drug discovery market segments and geographies, artificial intelligence (AI) in drug discovery market trends , Artificial Intelligence (AI) in Drug Discovery market players, revenue, profiles and market shares of key competitors. The Artificial Intelligence (AI) in Drug Discovery Market report identifies key countries and segments for opportunities and strategies based on market trends and key competitor approaches.
The Artificial Intelligence (AI) in TBRC Drug Discovery Market 2022 Global Market Report includes information on the following:
Data segmentation: market size, global, by region and country, historical and forecast, and growth rate for 60 geographies
Major Market Players: IBM Corporation, Microsoft, Atomwise Inc., Deep Genomics, Cloud Pharmaceuticals, Insilico Medicine, Benevolent AI, Exscientia, Cyclica and BIOAGE.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, United States, South America, Middle East and Africa.
Country: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Looking for something else? Here is a list of similar reports from The Business Research Company:
Global AI in Pharmaceutical Market Report 2021
Global Artificial Intelligence Market Report 2021
Global Artificial Intelligence Services Market Report 2021
About the Business Research Company
The Business Research Company has published over 1,000 industry reports covering over 2,500 market segments and 60 geographies. The reports are based on 150,000 datasets, extensive secondary research and proprietary insights from interviews with industry leaders. Reports are updated with a detailed analysis of the impact of COVID-19 on various markets.